- Report
- April 2024
- 91 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- April 2024
- 85 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- March 2024
- 103 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- March 2024
- 108 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- March 2024
- 83 Pages
Africa, Middle East
From €3280EUR$3,450USD£2,755GBP
- Report
- March 2024
- 95 Pages
Asia Pacific
From €3280EUR$3,450USD£2,755GBP
- Report
- September 2018
- 514 Pages
Global
From €3326EUR$3,499USD£2,794GBP
- Report
- January 2024
- 251 Pages
Global
From €5359EUR$5,835USD£4,350GBP
- Report
- January 2023
- 330 Pages
Global
From €4866EUR$5,298USD£3,950GBP
- Report
- December 2022
- 250 Pages
Global
From €4866EUR$5,298USD£3,950GBP
- Report
- July 2022
- 215 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- March 2024
- 382 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2024
- 204 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- June 2022
- 225 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- November 2020
- 286 Pages
Global
From €3327EUR$3,500USD£2,795GBP
- Report
- September 2023
- 160 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- June 2022
- 117 Pages
Global
From €5229EUR$5,500USD£4,393GBP
- Report
- November 2019
- 72 Pages
Global
From €856EUR$900USD£719GBP
- Report
- May 2023
- 102 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- October 2023
- 87 Pages
Global
From €4706EUR$4,950USD£3,953GBP

The Spinal Cord Stimulator (SCS) is a type of medical device used to treat chronic pain in the lower back, neck, and limbs. It works by sending electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain. SCS is a form of neuromodulation, which is a type of therapy that uses electrical stimulation to modify nerve activity. It is used to treat a variety of conditions, including failed back surgery syndrome, complex regional pain syndrome, and peripheral neuropathy.
SCS is a minimally invasive procedure, and is typically used when other treatments have failed. It is typically implanted in the lower back, and is connected to a small battery-powered device that is worn externally. The device is programmed to deliver electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain.
The SCS market is a growing segment of the neurology devices market. It is expected to continue to grow as more patients seek out minimally invasive treatments for chronic pain.
Some companies in the SCS market include Medtronic, Boston Scientific, St. Jude Medical, and Nevro. Show Less Read more